BioCentury
ARTICLE | Company News

CeNeS launches Xefo

September 6, 2001 7:00 AM UTC

Neurological company CeNeS (LSE:CEN) launched in the U.K. its Xefo non-steroidal anti-inflammatory drug (NSAID) to treat post-operative pain. CEN licensed the product from Nycomed Pharma (Oslo, Norway...